OPRM1 and X-linked cone dysfunction syndrome with myopia: Pharmacotherapies targeting the mu opioid receptor have illustrated the potential benefits of opiate antagonists in the treatment of BED, in that studies have found that opiate antagonists decrease food intake and food seeking behavior in human and animal models (Cambridge et al., 2013).